Co-Authors
This is a "connection" page, showing publications co-authored by Sergio Babudieri and Giordano Madeddu.
Connection Strength
1.636
-
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome. Front Public Health. 2021; 9:704520.
Score: 0.240
-
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS One. 2021; 16(3):e0248009.
Score: 0.234
-
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020056.
Score: 0.225
-
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine. 2019 08 14; 37(35):4906-4919.
Score: 0.208
-
Tache Noire in a Patient with Acute Q Fever. Med Princ Pract. 2018; 27(1):92-94.
Score: 0.187
-
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients. Laryngoscope. 2021 10; 131(10):2312-2318.
Score: 0.060
-
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol. 2022 Feb; 279(2):811-816.
Score: 0.059
-
The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients. J Infect Dev Ctries. 2021 Mar 31; 15(3):353-359.
Score: 0.059
-
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients. Eur J Clin Invest. 2021 Jan; 51(1):e13427.
Score: 0.057
-
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 2020 Jul; 42(7):1560-1569.
Score: 0.055
-
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020 06; 42(6):1252-1258.
Score: 0.055
-
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials. Medicina (Kaunas). 2019 Feb 08; 55(2).
Score: 0.051
-
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA. J Viral Hepat. 2018 12; 25(12):1406-1422.
Score: 0.049
-
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy. Int J Drug Policy. 2018 09; 59:50-53.
Score: 0.048
-
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area. Epidemiol Rev. 2018 06 01; 40(1):105-120.
Score: 0.048